

Suma Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.45 Cr
- Company Age 33 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 58.58 Cr
- Satisfied Charges ₹ 26.16 Cr
- Revenue Growth -31.83%
- Profit Growth -25.71%
- Ebitda 36.03%
- Net Worth 15.21%
- Total Assets 55.44%
About Suma Pharmaceuticals
Suma Pharmaceuticals Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 06 August 1991 and has a history of 33 years and nine months. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Fast Real Honest Fabricators Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.45 Cr.
The company currently has active open charges totaling ₹58.58 Cr. The company has closed loans amounting to ₹26.16 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ganpat Patil and Sumati Patil serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U27100MH1991PTC062830
- Company No.
062830
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Aug 1991
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Suma Pharmaceuticals?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ganpat Patil ![]() | Director | 28-Dec-1997 | Current |
Sumati Patil ![]() | Director | 28-Dec-1997 | Current |
Financial Performance of Suma Pharmaceuticals.
Suma Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 31.83% decrease. The company also saw a substantial fall in profitability, with a 25.71% decrease in profit. The company's net worth Soared by an impressive increase of 15.21%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Suma Pharmaceuticals?
In 2023, Suma Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Suma Chemicals Pvt. Ltd.
Ganpat Patil and Sumati Patil are mutual person
- Aromatic And Industrial Chemicals Private Limited
Ganpat Patil and Sumati Patil are mutual person
- Chikhloli Morivli Effluent Treatment
Ganpat Patil is a mutual person
Charges (Loans)
₹58.58 Cr
₹26.16 Cr
Charges Breakdown by Lending Institutions
- Bank Of India : 58.58 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
24 May 2023 | Bank Of India | ₹29.29 Cr | Open |
15 Mar 2023 | Bank Of India | ₹29.29 Cr | Open |
29 Jun 2022 | Others | ₹2.30 Cr | Satisfied |
19 Apr 2022 | Others | ₹1.04 Cr | Satisfied |
31 Dec 2021 | Others | ₹1.00 Cr | Satisfied |
How Many Employees Work at Suma Pharmaceuticals?
Suma Pharmaceuticals has a workforce of 15 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Suma Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suma Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Suma Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Suma Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Charges
A charge with Bank Of India amounted to Rs. 29.29 Cr with Charge ID 100731805 was registered on 24 May 2023.
- Charges
A charge registered on 31 Dec 2021 via Charge ID 100539700 with Others was fully satisfied on 05 May 2023.
- Charges
A charge registered on 30 Sep 2018 via Charge ID 100231323 with Others was fully satisfied on 05 May 2023.
- Charges
A charge registered on 29 Jun 2022 via Charge ID 100587842 with Others was fully satisfied on 26 Apr 2023.
- Charges
A charge registered on 19 Apr 2022 via Charge ID 100563706 with Others was fully satisfied on 26 Apr 2023.
Frequently asked questions
What is the Incorporation or founding date of Suma Pharmaceuticals Private Limited?
Suma Pharmaceuticals Private Limited was incorporated on 06 Aug 1991.
What is authorized share capital and paid-up capital of Suma Pharmaceuticals Private Limited?
The authorized share capital of Suma Pharmaceuticals Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 1.45 Cr.
Who are the current board members & directors of Suma Pharmaceuticals Private Limited?
Currently 2 directors are associated with Suma Pharmaceuticals Private Limited.
- Ganpat Mahadev Patil
- Sumati Ganpat Patil
What is the registered address of Suma Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Suma Pharmaceuticals Private Limited is Plot No.126 Chikhloli, Midc New Bhendipada India, Ambernath, Maharashtra, 421501.
What is the corporate identification number (CIN) and company number of Suma Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Suma Pharmaceuticals Private Limited is U27100MH1991PTC062830 and the company number is 062830 as per Ministry of Corporate Affairs (MCA).
What is the official website of Suma Pharmaceuticals Private Limited?
The Official website of Suma Pharmaceuticals Private Limited is https://www.sumapharma.in
What has been the recent revenue trend for Suma Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Suma Pharmaceuticals Private Limited has fallen by -31.83%.
How many employees does Suma Pharmaceuticals Private Limited currently have?
As Per 2023 financial reports, 15 employees are currently employed by Suma Pharmaceuticals Private Limited.
What change has been observed in the net worth of Suma Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Suma Pharmaceuticals Private Limited has experienced an upsurge of 15.21%.
What are the total open charges for Suma Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Suma Pharmaceuticals Private Limited amount to ₹ 58.58 Cr.
When was the last Balance Sheet of Suma Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Suma Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records